Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-15-activated donor NK cell infusion after allogeneic HSCT for pediatric leukemia
NL-OMON26066Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2013
- Countries
- 1
01
Overview
Open-label, single-arm trial in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), sponsored by Leiden University Medical Center. Primary endpoints: Feasibility of IMP manufacturing and infusion and Safety and tolerability of NK cell infusion. Started Jul 2013; status: recruiting.
02
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NL-OMON26066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26066.